Avita has announced today a development and distribution agreement with Regenity Biosciences for a resorbable collagen dermal matrix.
The newly-developed matrix is expected to receive 510(k) clearance later this year and Avita intends to trial the matrix, versus other commercially available matrices, in combination with Recell in two-stage grafting. An additional trial will assess the matrix combined with Recell in a single stage grafting procedure.
The source of collagen isn’t specified but other Regenity bioresorbable collagen products that have been cleared by the FDA are sourced from bovine dermis.
Avita has announced today a development and distribution...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.74 |
Change
0.060(2.24%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.76 | $2.66 | $2.585M | 948.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 20223 | $2.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.74 | 14024 | 12 |
View Market Depth
| Last trade - 12.54pm 01/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |